Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANE SHEETS

v3.19.3
CONDENSED CONSOLIDATED BALANE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 64,667 $ 96,473
Accounts receivable, net 140,765 143,907
Inventory, net 50,109 42,299
Other current assets and prepaid expenses 37,301 35,052
Total current assets 292,842 317,731
Property, plant and equipment, net 128,519 144,674
Intangible assets, net 564,310 614,452
In-process research and development 635,000 635,572
Goodwill 695,798 700,193
Investments 11,695 31,228
Operating lease right-of-use assets 35,826  
Other assets 5,528 7,222
Total assets 2,369,518 2,451,072
Current liabilities:    
Accounts payable 77,296 47,395
Accrued expenses 172,734 203,513
Current maturities of operating leases 12,921  
Current portion of convertible notes 0 31,562
Current portion of lines of credit and notes payable 7,187 5,851
Total current liabilities 270,138 288,321
Operating lease liabilities 23,318  
Convertible notes 208,695 57,299
Deferred tax liabilities, net 113,479 115,193
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 111,959 198,968
Total long-term liabilities 457,451 371,460
Total liabilities 727,589 659,781
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 and 750,000,000 shares authorized at September 30, 2019 and December 31, 2018, respectively; 616,150,952 and 586,881,720 shares issued at September 30, 2019 and December 31, 2018, respectively 6,162 5,869
Treasury Stock - 549,907 and 549,907 shares at September 30, 2019 and December 31, 2018, respectively (1,791) (1,791)
Additional paid-in capital 3,065,059 3,004,422
Accumulated other comprehensive loss (28,774) (20,131)
Accumulated deficit (1,398,727) (1,197,078)
Total shareholders’ equity 1,641,929 1,791,291
Total liabilities and equity $ 2,369,518 $ 2,451,072